Wednesday, September 29, 2021
8:00 am - 9:00 am
Virtual via Zoom (contact email@example.com for details)
Stacey Akers, MD: Division Director, Department of Gynecologic Oncology, Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York
Objectives: Understanding homologous recombination repair/deficiency, Role of PARP inhibitors in ovarian cancer treatment.